Clinical Trial: Dinaciclib in Treating Patients With Stage IV Melanoma

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: A Phase II Trial of SCH 727965 (NSC 747135) in Patients With Stage IV Melanoma

Brief Summary: This phase II trial is studying the side effects and how well dinaciclib works in treating patients with stage IV melanoma. Dinaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.